Comparison of surgical treatments for central retinal vein occlusion; Ron vs. cannulation of tissue plasminogen activator into the retinal vein

Retina

Volumn 29, Issue 8, 2009, Pages 1167-1174

  Yamamoto, Takuhiro ^a,b   Kamei, Motohiro ^a   Sakaguchi, Hirokazu ^a   Oshima, Yusuke ^a   Ikuno, Yasushi ^a   Gomi, Fumi ^a   Ohji, Masato ^c   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b LERNER RESEARCH INSTITUTE   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Central retinal vein occlusion; Radial optic neurotomy; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CANNULATION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NEOVASCULAR GLAUCOMA; RADIAL OPTIC NEUROTOMY; RETINA MACULA EDEMA; RETINA VEIN; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD DEFECT;

AGED; CATHETERIZATION; FEMALE; FIBRINOLYTIC AGENTS; GLAUCOMA, NEOVASCULAR; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETINAL VEIN; RETINAL VEIN OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 70349150166     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181a46a5e     Document Type: Article

References (40)

1. Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C. The natural course of central retinal vein occlusion. Am J Ophthal-mol 1990;110:118-123.
2. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997; 115:486-491.
3. Laatikainen L, Kohner EM, Khoury D, Blach RK. Panretinal photocoagulation in central retinal vein occlusion: a randomised controlled clinical study. Br J Ophthalmol 1977;61:741-753.
4. McAllister IL and Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of non-ischemic CRVO. Arch Ophthalmol 1995;113:456-462.
5. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
6. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 2004;24:348-355.
7. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004;242:273-278.
8. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasmino-gen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434.
9. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-613.
10. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-223.
11. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
12. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolo-neacetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240: 782-783.
13. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-1136.
14. Lin JM, Chiu YT, Hung PT, Tsai YY. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide. Retina 2007;27: 180-189.
15. Wakabayashi T, Okada AA, Morimura Y, Kojima E, Asano Y, Hirakata A, Hida T. Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion. Retina 2004;24:964-967.
16. Glacet-Bernard A, Mahdavi KN, Coscas G, Zourdani A, Fardeau C. Macular grid photocoagulation in persistent macular edema due to central retinal vein occlusion. Eur J Oph-thalmol 1994;4:166-174.
17. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102: 1434-1444.
18. Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: central vein occlusion study group M report. Ophthalmology 1995;102:1425-1433.
19. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-415.
20. Williamson TH, Poon W, Whitefield L, Strothidis N, Jaycock P. A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003;87:1126-1129.
21. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE, Borkowski LM. Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina 2006;26:306-313.
22. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
23. Am J Ophthalmol 1998;126:142-144.
24. Weiss JN. Retinal surgery for treatment of central retinal vein occlusion. Ophthalmic Surg Lasers 2000;31:162-165.
25. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257.
26. Bynoe LA, Weiss JN. Retinal endovascular surgery and intra-vitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 2003;135:382-384.
27. Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endo-vascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007;114:716-723.
28. Takaya K, Suzuki Y, Nakazawa M. Massive hemorrhagic retinal detachment during radial optic neurotomy. Graefes Arch Clin Exp Ophthalmol 2006;244:265-267.
29. Schneider U, Inhoffen W, Grisanti S, Bartz-Schmidt KU. Characteristics of visual field defects by scanning laser ophthalmoscope microperimetry after radial optic neurotomy for central retinal vein occlusion. Retina 2005;25:704-712.
30. Central Vein Occlusion Study Group. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
31. Friedman SM. Optociliary venous anastomosis after radial optic neurotomy for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2003;34:315-317.
32. Nomoto H, Shiraga F, Yamaji H. Evaluation of radial optic neurotomy for central retinal vein occlusion by indocyanine green videoangiography and image analysis. Am J Ophthalmol 2004;138:612-619. (Pubitemid 39420490)
33. Spaide RF, Klancnik JM Jr, Gross NE. Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular edema. Retina 2004;24:356-359.
34. Malhotra S, Bali T, Thomas R. The question of radial optic neurotomy in central retinal vein occlusion. Arch Ophthalmol 2004;122:1573-1574.
35. Hasselbach HC, Ruefer F, Feltgen N, et al. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol 2007;245:1145-1156.
36. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevaci-zumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284.
37. Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007;245:1429-1436.
38. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone ace-tonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136: 419-425.
39. Williamson TH, O'Donnell A. Intravitreal triamcinolone ace-tonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 2005;139:860-866.
40. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 2005;83:71-75. (Pubitemid 40326425)